ECTRIMS eLearning

Is fatigue associated with exercise tolerance among patients suffering from multiple sclerosis?
Author(s): ,
M Valet
Affiliations:
IREC, UCL;Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
,
G Stoquart
Affiliations:
IREC, UCL;Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
,
Y Glibert
Affiliations:
Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
,
J.-C Hakizimana
Affiliations:
Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
T Lejeune
Affiliations:
IREC, UCL;Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
ECTRIMS Learn. Valet M. 09/14/16; 145679; EP1584
Maxime Valet
Maxime Valet
Contributions
Abstract

Abstract: EP1584

Type: ePoster

Abstract Category: RIMS - Neuropsychology and fatigue management

Objective: Fatigue is the most common and disabling symptom among patients suffering from Multiple Sclerosis (MS). Its underlying mechanisms are poorly understood. From the initial stages of the disease, a physical deconditioning is also observed among these patients. The aim of this study is to assess the cardiorespiratory endurance (i.e. exercise tolerance) and self-reported fatigue, as well as their associations with other functionnal parameters, among patients suffering from MS with mild disability (Expanded Disability Status Scale ≤ 4).

Material and methods: Twenty one patients with MS (15 women; age: 26-64 years, median 46 years; duration of disease: 0.33-48 years, median 7.25 years; EDSS 0-4, median 2.5; clinical forms: Relapsing -Remitting: 16, Primary Progressive: 4, Secondary Progressive: 1) ​​were evaluated. Cardiorespiratory endurance was assessed by a maximal exercise test on a cycle ergometer, from which different indices were extracted: VO2-max, Oxygen Uptake Efficiency Slope (OUES) at different points and Physical Working Capacity at 75% of maximal heart rate (PWC75%). The Timed Up-and-Go (TUG) test was performed to assess functional mobility. Perceived fatigue, anxiety and depression and quality of life were respectively assessed by the following questionnaires: Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale (FSS), Hospital Anxiety and Depression Scale (HADS) and Short Form Health Survey (SF-36v2).

Results: The majority of the patients (n = 13, 62%) presented a pathological level of perceived fatigue, based on the FSS criterion (FSS>5). The cardiorespiratory endurance indices are decreased among the patients, compared with the normative values from the general population. Low-to-moderate negative correlations (p < 0.05) are observed between perceived fatigue and VO2-max (FSS: r = -0.59; MFIS: r = -0.43). The OUES is weakly correlated with the MFIS (r = -0.40). Functional mobility (TUG) is moderately correlated to exercise tolerance (VO2-max: r= -0.56) and fatigue (MFIS: r = 0.64). Discussion: Our data show that our patients are deconditioned and most have pathological level of fatigue. This fatigue, as well as fonctionnal mobility, are correlated to physical deconditioning. Our findings suggest that improving exercise tolerance functions could help reducing fatigue and improving functional mobility among patients suffering from MS with mild neurological disability.

Disclosure: The research is funded by Fondation pour l"aide à la recherche dans la sclérose en plaques (ARSEP).

Valet Maxime: Nothing to disclose

Stoquart Gaetan: Nothing to disclose

Glibert Yumiko: Nothing to disclose

Hakizimana Jean-Claude: Nothing to disclose

Lejeune Thierry: Nothing to disclose

Abstract: EP1584

Type: ePoster

Abstract Category: RIMS - Neuropsychology and fatigue management

Objective: Fatigue is the most common and disabling symptom among patients suffering from Multiple Sclerosis (MS). Its underlying mechanisms are poorly understood. From the initial stages of the disease, a physical deconditioning is also observed among these patients. The aim of this study is to assess the cardiorespiratory endurance (i.e. exercise tolerance) and self-reported fatigue, as well as their associations with other functionnal parameters, among patients suffering from MS with mild disability (Expanded Disability Status Scale ≤ 4).

Material and methods: Twenty one patients with MS (15 women; age: 26-64 years, median 46 years; duration of disease: 0.33-48 years, median 7.25 years; EDSS 0-4, median 2.5; clinical forms: Relapsing -Remitting: 16, Primary Progressive: 4, Secondary Progressive: 1) ​​were evaluated. Cardiorespiratory endurance was assessed by a maximal exercise test on a cycle ergometer, from which different indices were extracted: VO2-max, Oxygen Uptake Efficiency Slope (OUES) at different points and Physical Working Capacity at 75% of maximal heart rate (PWC75%). The Timed Up-and-Go (TUG) test was performed to assess functional mobility. Perceived fatigue, anxiety and depression and quality of life were respectively assessed by the following questionnaires: Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale (FSS), Hospital Anxiety and Depression Scale (HADS) and Short Form Health Survey (SF-36v2).

Results: The majority of the patients (n = 13, 62%) presented a pathological level of perceived fatigue, based on the FSS criterion (FSS>5). The cardiorespiratory endurance indices are decreased among the patients, compared with the normative values from the general population. Low-to-moderate negative correlations (p < 0.05) are observed between perceived fatigue and VO2-max (FSS: r = -0.59; MFIS: r = -0.43). The OUES is weakly correlated with the MFIS (r = -0.40). Functional mobility (TUG) is moderately correlated to exercise tolerance (VO2-max: r= -0.56) and fatigue (MFIS: r = 0.64). Discussion: Our data show that our patients are deconditioned and most have pathological level of fatigue. This fatigue, as well as fonctionnal mobility, are correlated to physical deconditioning. Our findings suggest that improving exercise tolerance functions could help reducing fatigue and improving functional mobility among patients suffering from MS with mild neurological disability.

Disclosure: The research is funded by Fondation pour l"aide à la recherche dans la sclérose en plaques (ARSEP).

Valet Maxime: Nothing to disclose

Stoquart Gaetan: Nothing to disclose

Glibert Yumiko: Nothing to disclose

Hakizimana Jean-Claude: Nothing to disclose

Lejeune Thierry: Nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies